Jennifer Larson
CFO, Treasurer & Principal Accounting OfficerMs. Jennifer Larson, also known as Jenn, is Chief Financial Officer, Treasurer and Principal Accounting Officer of Bicara Therapeutics Inc. since August 12, 2026. She was Chief Financial Officer of Deciphera Pharmaceuticals, Inc until 2026 and was its Senior Vice President until March 2026. Ms. Larson was Senior Vice President of Finance & Investor Relations of Deciphera Pharmaceuticals, Inc. Ms. Larson joined Deciphera Pharmaceuticals, Inc. in 2019 as the Vice President of Finance and Investor Relations supporting the initial commercial scale-up of the business, including expansion outside the US. She has many years of diversified financial experience. Prior to joining Deciphera Pharmaceuticals, Inc., she served in various positions of increasing seniority at Alnylam Pharmaceuticals for over 12 years and earlier worked in the audit practice in public accounting. Ms. Larson is a Certified Public Accountant and graduated from the University of Massachusetts with a BS in Finance and Accounting.
Positions
- Company NameBicara Therapeutics Inc.Stock CodeBCAXPositionCFO, Treasurer & Principal Accounting OfficerColleagues
- CMClaire Mazumdar ClemonCEO & Director
- MFMichael F. PowellIndependent Chairman of the Board
- RCRyan CohlheppPresident, COO & Director
- RFRachel FrankVice President of Investor Relations and Corporate Communications
- LSLara S. MeisnerChief Legal Officer, Compliance Officer & Corporate Secretary
- SRScott RobertsonIndependent Director
- JSJake SimsonNon Executive Independent Director
